Lv1
20 积分 2022-02-15 加入
Toripalimab en association avec cisplatine et gemcitabine pour le traitement des carcinomes indifférenciés du nasopharynx récidivants ou métastatique (UCNT RM) en première ligne
1天前
求助中
Efficacy and safety of autologous CIK cell therapy plus Toripalimab with or without chemotherapy in advanced NSCLC: A phase II study
1天前
已完结
The place of JAK inhibitors in systemic juvenile idiopathic arthritis with lung disease (SJIA-LD): French experience
12天前
已完结
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system
13天前
已完结
An Updated Comprehensive Pharmacovigilance Study of Drug‐Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data
13天前
已完结
Bilateral, sequential orbital inflammatory syndrome associated with ruxolitinib
13天前
已完结
Adverse event of ruxolitinib cream: a real-world analysis based on FDA adverse event reporting system from 2021 to 2024
13天前
已完结
Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial
20天前
已完结
Extended survival of a patient with gastrointestinal multiple malignancies managed with anti-PD-1 immunotherapy: a case report
1个月前
已完结
Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer
1个月前
已完结
皖公网安备34019202002308
